Pricesmart

US · PSMT #2079 by market cap Listed 1970

169.72 -2.28 -1.33%

Live - 5344 symbols - heartbeat 451s ago · 2026-10-08 04:19

Pre-market 169.72 0.00%

After-hours 169.72 0.00%

Market cap: 5.24B
P/E (TTM): 32.64
P/B: 3.76
EPS: 4.82
Div yield: 0.78%
52W pos: 67%

Reader sentiment Are you bullish or bearish on PSMT?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Financial Health how this is computed

Good

Altman Z-Score is 6.49, above the 3.0 "safe zone" threshold.
Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.

Revenue annual, last 8 years

Latest year +7.25% YoY

Margins

Gross margin: 17.35%
Operating margin: 4.48%
Net margin: 2.75%

Key ratios & quality

Enterprise value: 5.13B
PEG ratio: 2.66
Altman Z-Score: 6.49

PEG uses trailing P/E against the 3-year net income growth rate (12.26%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.

Income statement

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	3.17B	3.22B	3.33B	3.62B	4.07B	4.41B	4.91B	5.27B
Gross profit	510.18M	528.23M	554.41M	644.53M	681.15M	759.33M	846.92M	914.37M
Selling & admin expenses	379.95M	409.26M	429.95M	484.64M	511.35M	552.06M	622.84M	678.27M
Research & development	--	--	--	--	--	--	--	--
Operating profit	130.23M	118.97M	124.46M	159.90M	169.80M	200.10M	224.08M	236.10M
Pretax profit	122.59M	111.11M	116.04M	147.19M	156.42M	169.21M	201.43M	206.50M
Tax	48.18M	37.56M	37.76M	48.97M	51.86M	59.95M	62.62M	58.62M
Net profit	74.40M	73.49M	78.18M	98.16M	104.55M	109.21M	138.88M	147.89M
Basic EPS	2	2	3	3	3	4	5	5
Diluted EPS	2.44	2.40	2.55	3.18	3.38	3.50	4.57	4.82

Line item	2025-02	2025-05	2025-08	2025-11	2026-02	2026-05
Revenue	1.36B	1.32B	1.33B	1.38B	1.50B	1.48B
Gross profit	233.75M	229.65M	231.92M	244.39M	265.07M	262.22M
Selling & admin expenses	167.27M	172.82M	177.77M	181.12M	189.21M	195.71M
Research & development	--	--	--	--	--	--
Operating profit	66.49M	56.84M	54.15M	63.26M	75.87M	66.51M
Pretax profit	60.16M	49.07M	46.34M	55.70M	66.69M	55.14M
Tax	16.38M	13.92M	14.82M	15.53M	17.60M	15.45M
Net profit	43.76M	35.16M	31.54M	40.17M	49.09M	39.69M
Basic EPS	1	1	1	1	2	1
Diluted EPS	1.45	1.14	1.02	1.29	1.62	1.28

Balance sheet

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Total current assets	487.85M	491.90M	699.00M	697.20M	773.58M	877.11M	832.35M	974.46M
Cash & ST investments	125.76M	119.70M	345.99M	252.29M	248.87M	331.07M	225.53M	314.21M
Inventory	321.03M	331.27M	309.51M	389.71M	464.41M	471.41M	528.68M	560.73M
Total assets	1.22B	1.30B	1.66B	1.71B	1.81B	2.01B	2.02B	2.27B
Total current liabilities	349.37M	407.45M	568.28M	533.55M	579.46M	634.48M	680.15M	726.27M
Short-term debt	14.86M	33.42M	93.17M	27.92M	51.81M	36.49M	51.29M	58.89M
Long-term debt	87.72M	63.71M	112.61M	110.11M	103.56M	119.49M	94.44M	147.92M
Total liabilities	457,754,000.00	498,132,000.00	824,093,000.00	789,576,000.00	817,327,000.00	898,565,000.00	899,729,000.00	1,021,785,000.00
Total equity	758.64M	798.28M	832.73M	916.21M	991.07M	1.11B	1.12B	1.25B
Retained earnings	473.95M	525.80M	582.49M	658.92M	736.89M	817.56M	890.27M	999.43M

Line item	2025-02	2025-05	2025-08	2025-11	2026-02	2026-05
Total current assets	875.14M	900.78M	974.46M	1.05B	1.04B	1.06B
Cash & ST investments	247.30M	262.37M	314.21M	320.58M	305.96M	322.19M
Inventory	549.69M	553.12M	560.73M	618.85M	623.14M	623.05M
Total assets	2.09B	2.14B	2.27B	2.39B	2.44B	2.52B
Total current liabilities	701.81M	701.79M	726.27M	788.90M	805.24M	833.01M
Short-term debt	40.92M	42.99M	58.89M	52.17M	46.11M	76.67M
Long-term debt	88.85M	86.17M	147.92M	143.74M	129.15M	114.37M
Total liabilities	920,079,000.00	930,247,000.00	1,021,785,000.00	1,089,108,000.00	1,103,719,000.00	1,126,795,000.00
Total equity	1.17B	1.21B	1.25B	1.30B	1.33B	1.39B
Retained earnings	932.67M	967.83M	999.43M	1.04B	1.05B	1.09B

Cash flow

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Operating cash flow	119.45M	170.33M	259.27M	127.17M	121.83M	257.33M	207.59M	261.31M
Depreciation & amortization	52.64M	54.96M	61.23M	64.98M	67.87M	72.70M	82.61M	88.16M
Free cash flow	21.35M	30.27M	158.95M	13.99M	1.17M	114.82M	39.04M	103.17M
Dividends paid	-21.24M	-21.65M	-21.53M	-21.99M	-26.56M	-28.54M	-66.16M	-38.73M
Stock buybacks / issuance	-3.18M	-4.60M	-3.65M	-5.54M	-6.26M	-12.86M	-73.49M	-6.71M
Ending cash balance	96.91M	106.24M	303.77M	215.48M	251.37M	252.20M	136.31M	285.29M

Line item	2025-02	2025-05	2025-08	2025-11	2026-02	2026-05
Operating cash flow	87.86M	52.78M	82.15M	71.25M	62.04M	58.92M
Depreciation & amortization	21.77M	22.76M	22.78M	23.98M	24.27M	24.78M
Free cash flow	53.22M	14.00M	25.60M	32.63M	12.31M	3.20M
Dividends paid	--	0	-19.36M	--	--	0
Stock buybacks / issuance	-2.46M	-105.00K	-853.00K	-5.07M	-3.73M	-113.00K
Ending cash balance	145.50M	183.12M	285.29M	249.56M	195.09M	254.62M

Returns & efficiency

Line item	2018	2019	2020	2021	2022	2023	2024	2025
ROE %	10.01	9.32	9.49	11.21	10.84	10.28	12.30	12.23
ROA %	6.13	5.77	5.23	5.83	5.88	5.66	6.81	6.75
ROIC %	9.03	8.44	7.88	8.66	8.84	8.20	10.04	9.89
5-year avg ROE %	14.26	12.60	11.34	10.65	10.16	10.22	10.79	11.34
EBIT margin %	4.03	3.57	3.71	4.27	4.08	4.09	4.36	4.14
FCF / sales %	0.67	0.94	4.77	0.39	0.03	2.60	0.79	1.96
Current ratio	1.40	1.21	1.23	1.31	1.34	1.38	1.22	1.34
Quick ratio	0.39	0.32	0.63	0.50	0.45	0.55	0.36	0.46
Debt / assets	8.43	7.49	19.92	15.67	15.14	13.87	12.34	14.50
LT debt / equity	11.57	7.99	28.47	26.15	22.41	21.83	17.66	21.66
Interest coverage	25.17	29.21	16.22	21.41	17.28	16.35	16.54	18.93
Revenue CAGR (3Y) %	4.16	3.53	3.57	4.56	8.04	9.84	10.72	9.03
Net income CAGR (3Y) %	-5.87	-6.21	-4.87	9.64	12.62	11.82	12.34	12.26
FCF CAGR (3Y) %	1.53	-22.26	--	-13.13	-66.20	-10.27	40.79	345.23

Line item	2025-02	2025-05	2025-08	2025-11	2026-02	2026-05
ROE %	12.42	12.34	12.23	11.97	12.20	12.06
ROA %	6.81	6.85	6.75	6.58	6.75	6.74
ROIC %	10.29	10.19	9.89	9.85	10.15	10.03
5-year avg ROE %	--	--	--	--	--	--
EBIT margin %	4.17	4.13	4.14	4.16	4.21	4.21
FCF / sales %	1.54	1.80	1.96	2.33	1.53	1.30
Current ratio	1.25	1.28	1.34	1.33	1.29	1.28
Quick ratio	0.38	0.40	0.46	0.43	0.41	0.41
Debt / assets	11.29	11.57	14.50	13.58	12.73	12.92
LT debt / equity	16.65	16.89	21.66	20.92	19.80	17.87
Interest coverage	17.54	18.93	18.93	16.96	15.86	15.21
Revenue CAGR (3Y) %	--	--	--	--	--	--
Net income CAGR (3Y) %	--	--	--	--	--	--
FCF CAGR (3Y) %	--	--	--	--	--	--

✦ Quant Revenue Concentration how this is computed

Diversified

Foods & Sundries is the largest reported line at 44.76% of revenue, across 9 reported segments.
No single line clears half of revenue; Fresh Foods is next at 30.42%, spreading the business across more than one real driver.

Revenue breakdown most recent period

Business

Foods & Sundries44.76%

Fresh Foods30.42%

Hardlines10.87%

Softlines6.67%

Food Service and Bakery4.37%

Membership income1.64%

Health services0.97%

Other revenue and income0.28%

Quote time 2026-10-08 04:19:36 · For reference only, not investment advice and not tailored to your situation.